Ogata R T, Low P J, Bradt B M, Cooper N R
Medical Biology Institute, La Jolla, CA 92037.
J Immunol. 1994 Jun 15;152(12):5890-5.
An early step in the initiation of the classical C pathway is the proteolytic activation of component C4 by subcomponent C1-s. We have examined the substrate specificity of murine C1-s (mC1-s) by measuring its proteolytic activity on human and murine C4, and on the murine C4 isotype designated sex-limited protein (Slp). The latter substrate was examined because previous studies have demonstrated that Slp is not cleaved by C1-s, and hence Slp has been assumed to be nonfunctional in the C pathways. Those earlier studies used human, not murine, C1-s, however; a recent report has suggested that Slp is an essential component of a novel complement activation pathway and that the previous failure to observe cleavage of Slp is probably the result of a species incompatibility between Slp and the heterologous human C1-s (hC1-s). The present studies do not support this idea, as we found no evidence of cleavage of Slp by homologous murine C1-s even at enzyme concentrations 10-fold higher than that necessary for 50% cleavage of murine C4 (mC4). We did find a species-specific affect in the cleavage of mC4, where mC1-s is about 10-fold more effective than heterologous hC1-s in cleaving mC4, but mC1-s itself does not distinguish between human and murine C4, cleaving both equally well. Hence mC1-s does not exhibit the species specificity previously found for hC1-s, which shows a several hundred-fold preference for homologous human C4 over murine C4.
经典补体途径激活的早期步骤之一是C1s亚成分对C4成分的蛋白水解激活。我们通过测量小鼠C1s(mC1s)对人及小鼠C4以及对小鼠C4同种型即性限制蛋白(Slp)的蛋白水解活性,研究了mC1s的底物特异性。之所以研究后一种底物,是因为先前的研究表明Slp不会被C1s切割,因此Slp被认为在补体途径中无功能。然而,那些早期研究使用的是人而非小鼠的C1s;最近一份报告表明Slp是一种新型补体激活途径的重要成分,之前未能观察到Slp的切割可能是由于Slp与异源人C1s(hC1s)之间的种属不兼容性。本研究不支持这一观点,因为我们发现即使酶浓度比小鼠C4(mC4)50%切割所需浓度高10倍,同源小鼠C1s也没有切割Slp的证据。我们确实在mC4的切割中发现了种属特异性影响,其中mC1s在切割mC4方面比异源hC1s有效约10倍,但mC1s本身并不能区分人C4和小鼠C4,对两者的切割效果相同。因此,mC1s没有表现出先前在hC1s中发现的种属特异性,hC1s对同源人C4的偏好比对小鼠C4高数百倍。